The company continues making progress on its 2024 development priorities: Advancing its RAS (ON) multi-selective inhibitor RMC-6236 into monotherapy pivotal trials. As data from the first-in-human ...

Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial ...

Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2024.

Beyond Meat, Inc. (BYND) revealed Loss for first quarter that decreased from the same period last year but missed the Street ...

CoreCivic Inc (CXW) revealed a profit for first quarter that decreased from last year but beat the Street estimates. The company's ...

Royal Gold Inc. (RGLD) revealed a profit for first quarter that decreased from last year and missed the Street estimates. The ...

First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising ...

EL SEGUNDO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, today reported financial results for its first ...

Company announces positive initial Phase 1a dose escalation data for monotherapy CX-904 (EGFRxCD3 T-cell engager) in solid tumors -- First dose ...

ISSAQUAH, Wash., May 08, 2024 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $19.80 billion for the retail month of April, the ...

Stocks showed a lack of direction over the course of the trading day on Wednesday, extending the lackluster performance seen during ...

Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced its newest community, Ridgeline at ...